Survival benefit of adjuvant radiotherapy in stage III and IV bladder cancer: results of 170 patients
Yasser Bayoumi,1 Tarek Heikal,2 Hossam Darweish2 1Radiation Oncology, National Cancer Institute, Cairo University, Giza, Egypt; 2Medical Oncology, Damietta Cancer Institute, Ministry of Health, Damietta, Egypt Background: Radical cystectomy (RC) with or without neoadjuvant chemotherapy is the stand...
Main Authors: | Bayoumi Y, Heikal T, Darweish H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-11-01
|
Series: | Cancer Management and Research |
Online Access: | http://www.dovepress.com/survival-benefit-of-adjuvant-radiotherapy-in-stage-iii-and-iv-bladder--peer-reviewed-article-CMAR |
Similar Items
-
Survival benefit after neoadjuvant or adjuvant radiotherapy for stage II–III gastroesophageal junction adenocarcinoma: A large population-based cohort study
by: Zhichao Zuo, et al.
Published: (2022-10-01) -
Analysis of the efficacy and factors influencing survival of adjuvant radiotherapy for stage II-III biliary tract carcinoma
by: Yan-Ling Guo, et al.
Published: (2023-10-01) -
Adjuvant nivolumab for stage III/IV melanoma: evaluation of safety outcomes and association with recurrence-free survival
by: James Larkin, et al.
Published: (2021-08-01) -
Impact of adjuvant radiotherapy on the survival of women with optimally resected stage III endometrial cancer in the era of modern radiotherapy: a retrospective study
by: Jenny Ling-Yu Chen, et al.
Published: (2020-04-01) -
Development and validation of nomogram models to predict radiotherapy or chemotherapy benefit in stage III/IV gastric adenocarcinoma with surgery
by: Xiangqing Ren, et al.
Published: (2023-08-01)